ÂÜÀòÂÒÂ×

Vincent DEWOLFS serves as a Senior Quality Assurance Engineer at Prothya Biosolutions since January 2020 and holds the position of Chief Executive Officer at Glanzal-Trading since December 2012. With extensive experience in the pharmaceutical industry, Vincent DEWOLFS worked as a Consultant in Pharma Services at Pauwels Consulting from October 2013 to October 2019 and as a Site Compliance Project Engineer for Pfizer from February 2015 to December 2018, where responsibilities included site quality authority and inspection processes. Prior roles include expertise in regulatory affairs at Schering-Plough Pharmaceuticals, project engineering at Alcon, and facilities expertise at GSK. Vincent DEWOLFS has earned multiple degrees from KU Leuven, including a Ph.D. focused on pediatric drug availability, and holds a Master's degree in Biomedical Sciences. Additionally, Vincent DEWOLFS completed studies in Polish and Bio-Pharmacy, alongside high school education in Modern Languages and Mathematics.